Search

everythinglearnresearchcommunity

for

Search:↓

Genetics and hormones cause hair loss; finasteride treats it safely.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Finasteride safely reduces excessive hair growth in women.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

The enzyme myo-inositol oxygenase is not linked to the cause of polycystic ovarian syndrome.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.